High critical current density and enhanced pinning in superconducting films of YBa2Cu3O7-δ nanocomposites with embedded BaZrO3, BaHfO3, BaTiO3, and SrZrO3 nanocrystals

Chemical solution deposition (CSD) of YBa2Cu3O7−δ (YBCO) nanocomposites from colloidal precursor solutions containing double metal oxide preformed nanocrystals is a promising, cost effective and reproducible approach to produce superconducting films with high critical current density (Jc) and enhanced pinning. Here, the influence of the preformed nanocrystal composition on the microstructure and superconducting properties of the YBCO nanocomposite films is studied, with a focus on establishing a simple and scalable process to grow nanocomposites that can be transferred to grow nano-added coated conductors. Colloidal stable BaZrO3, BaHfO3, BaTiO3 and SrZrO3 nanocrystals (3-6 nm in diameter) were synthesized and added to an environment-friendly low-fluorine YBCO precursor solution. High-quality superconducting layers were grown on LaAlO3 single-crystal substrates from these four nanocomposite precursor solutions in a single deposition process, without the need of a seed layer, yielding Jc of 4-5 MA/cm² at 77 K in self-field. The different YBCO microstructures produced by the four types of nanocrystals and the resulting microstrain of the films are compared and related with the magnetic-field and angular dependence of Jc. We demonstrate the BaHfO3-containing nanocomposite as the best-performing with a homogeneous distribution of nanoparticles with 7 nm in average diameter and a high density of stacking faults, which leads to some of the best superconducting properties ever achieved via low-fluorine CSD. The Jc exhibits a much smoother decay in applied magnetic fields and a much more isotropic behaviour for non-parallel magnetic fields, and the pinning force is increased by a factor of 3.5 at 77 K and 1 T with respect to the pristine film

Genotoxic mechanisms for the carcinogenicity of the environmental pollutants and carcinogens o-anisidine and 2-nitroanisole follow from adducts generated by their metabolite N-(2-methoxyphenyl)-hydroxylamine with deoxyguanosine in DNA

An aromatic amine, o-anisidine (2-methoxyaniline) and its oxidative counterpart, 2-nitroanisole (2-methoxynitrobenzene), are the industrial and environmental pollutants causing tumors of the urinary bladder in rats and mice. Both carcinogens are activated to the same proximate carcinogenic metabolite, N-(2-methoxyphenyl)hydroxylamine, which spontaneously decomposes to nitrenium and/or carbenium ions responsible for formation of deoxyguanosine adducts in DNA in vitro and in vivo. In other words, generation of N-(2-methoxyphenyl)hydroxylamine is responsible for the genotoxic mechanisms of the o-anisidine and 2-nitroanisole carcinogenicity. Analogous enzymes of human and rat livers are capable of activating these carcinogens. Namely, human and rat cytochorme P4502E1 is the major enzyme oxidizing o-anisidine to N-(2-methoxyphenyl)hydroxylamine, while xanthine oxidase of both species reduces 2-nitroanisole to this metabolite. Likewise, O-demethylation of 2-nitroanisole, which is the detoxication pathway of its metabolism, is also catalyzed by the same human and rat enzyme, cytochorme P450 2E1. The results demonstrate that the rat is a suitable animal model mimicking the fate of both carcinogens in humans and suggest that both compounds are potential carcinogens also for humans

COVID-19 trajectories among 57 million adults in England: a cohort study using electronic health records

BACKGROUND: Updatable estimates of COVID-19 onset, progression, and trajectories underpin pandemic mitigation efforts. To identify and characterise disease trajectories, we aimed to define and validate ten COVID-19 phenotypes from nationwide linked electronic health records (EHR) using an extensible framework. METHODS: In this cohort study, we used eight linked National Health Service (NHS) datasets for people in England alive on Jan 23, 2020. Data on COVID-19 testing, vaccination, primary and secondary care records, and death registrations were collected until Nov 30, 2021. We defined ten COVID-19 phenotypes reflecting clinically relevant stages of disease severity and encompassing five categories: positive SARS-CoV-2 test, primary care diagnosis, hospital admission, ventilation modality (four phenotypes), and death (three phenotypes). We constructed patient trajectories illustrating transition frequency and duration between phenotypes. Analyses were stratified by pandemic waves and vaccination status. FINDINGS: Among 57 032 174 individuals included in the cohort, 13 990 423 COVID-19 events were identified in 7 244 925 individuals, equating to an infection rate of 12·7% during the study period. Of 7 244 925 individuals, 460 737 (6·4%) were admitted to hospital and 158 020 (2·2%) died. Of 460 737 individuals who were admitted to hospital, 48 847 (10·6%) were admitted to the intensive care unit (ICU), 69 090 (15·0%) received non-invasive ventilation, and 25 928 (5·6%) received invasive ventilation. Among 384 135 patients who were admitted to hospital but did not require ventilation, mortality was higher in wave 1 (23 485 [30·4%] of 77 202 patients) than wave 2 (44 220 [23·1%] of 191 528 patients), but remained unchanged for patients admitted to the ICU. Mortality was highest among patients who received ventilatory support outside of the ICU in wave 1 (2569 [50·7%] of 5063 patients). 15 486 (9·8%) of 158 020 COVID-19-related deaths occurred within 28 days of the first COVID-19 event without a COVID-19 diagnoses on the death certificate. 10 884 (6·9%) of 158 020 deaths were identified exclusively from mortality data with no previous COVID-19 phenotype recorded. We observed longer patient trajectories in wave 2 than wave 1. INTERPRETATION: Our analyses illustrate the wide spectrum of disease trajectories as shown by differences in incidence, survival, and clinical pathways. We have provided a modular analytical framework that can be used to monitor the impact of the pandemic and generate evidence of clinical and policy relevance using multiple EHR sources. FUNDING: British Heart Foundation Data Science Centre, led by Health Data Research UK

Solution-derived YBa 2_{2} Cu 3_{3} O 7−δ_{7−δ} (YBCO) superconducting films with BaZrO 3_{3} (BZO) nanodots based on reverse micelle stabilized nanoparticles

Superconducting YBa2Cu3O7-delta (YBCO) films with artificial BaZrO3 (BZO) nanodots were prepared using a chemical solution deposition method involving hybrid solutions composed of trifluoroacetate-based YBCO precursors and reverse micelle stabilized BZO nanoparticle dispersions. Microemulsion-mediated synthesis was used to obtain nano-sized (similar to 12 nm) and mono-dispersed BZO nanoparticles that preserve their features once introduced into the YBCO solution, as revealed by dynamic light scattering. Phase pure, epitaxial YBCO films with randomly oriented BZO nanodots distributed over their whole microstructure were grown from the hybrid solutions on (100) LaAlO3 substrates. The morphology of the YBCO-BZO nanocomposite films was strongly influenced by the amount of nanoparticles incorporated into the system, with contents ranging from 5 to 40 mol%. Scanning electron microscopy showed a high density of isolated second-phase defects consisting of BZO nanodots in the nanocomposite film with 10 mol% of BZO. Furthermore, a direct observation and quantitative analysis of lattice defects in the form of interfacial edge dislocations directly induced by the BZO nanodots was evidenced by transmission electron microscopy. The superconducting properties (77 K) of the YBCO films improved considerably by the presence of such nanodots, which seem to enhance the morphology of the sample and therefore the intergranular critical properties. The incorporation of preformed second-phase defects (here, BZO) during the growth of the superconducting phase is the main innovation of this novel approach for the all-solution based low-cost fabrication of long-length coated conductors

Oxygen doping effects in CSD-YBCO nanocomposite films with preformed nanocrystals

The present-day development of YBCO nanocomposite films via a low-cost chemical solution deposition strongly focuses on the optimization of flux pinning through the addition of preformed nanocrystals. Successful fabrication of such nanocomposite films with improved pinning properties has been demonstrated on the single-crystal and long-length textured substrates. The major goal of this study is to understand how the oxygen doping level influences the critical current of YBCO nanocomposite films. The effective nanocrystals being ~10 nm in size affect the strain state and cell volume of the YBCO matrix; the two effects should result in changes of the YBCO doping state. In this contribution, we present our results on the oxygenation kinetics, which appears to be strongly affected by the presence of nanoparticles and on variation in Tc and Jc of the MOD-TFA (YBCO + BaZrO3/BaHfO3) nanocomposite films deposited on industrial CeO2/LZO/NiW substrates as function of the oxygenation conditions

All-chemical YBa 2 Cu 3 O 7−δ coated conductors with preformed BaHfO 3 and BaZrO 3 nanocrystals on Ni5W technical substrate at the industrial scale

We report a successful fabrication of long-length rolling-assisted biaxially-textured substrate-based coated conductors (CCs) via chemical solution deposition starting from colloidal YBa2Cu3O7-delta (YBCO) solutions containing 5 mol-% preformed BaMO3 (M = Hf, Zr) (BMO) nanocrystals. Partial optimization of the existing continuous reel-to-reel YBCO processing via design of experiments approach allowed us to obtain YBCO nanocomposites that retain 80%-90% self-field performance of the pristine CC and show a 10%-40% improvement of in-field critical current, which is only a moderate performance improvement compared to similar films on single-crystal substrates prepared on lab-scale. Based on x-ray diffraction and transmission electron microscopy studies, we attribute this to worsening of the YBCO texture and strong coarsening of BMO nanoparticles, particularly, BaZrO3, during processing. Possible process improvements to overcome these effects are discussed